RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AUPH
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Wednesday for Aurinia Pharmaceuticals Inc
(Updated on Mar 27, 2024)

Sell candidate since Feb 13, 2024 Loss -35.73% PDF

The Aurinia Pharmaceuticals Inc stock price gained 1.42% on the last trading day (Wednesday, 27th Mar 2024), rising from $4.93 to $5.00. During the last trading day the stock fluctuated 3.30% from a day low at $4.85 to a day high of $5.01. The price has fallen in 6 of the last 10 days and is down by -4.76% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 462 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $7.00 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -42.38% during the next 3 months and, with a 90% probability hold a price between $2.57 and $3.49 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AUPH Signals & Forecast

There are mixed signals in the stock today. The Aurinia Pharmaceuticals Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $5.03 and $5.91. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Tuesday, March 26, 2024, and so far it has risen 1.42%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Aurinia Pharmaceuticals Inc stock

Aurinia Pharmaceuticals Inc finds support from accumulated volume at $4.99 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.160 between high and low, or 3.30%. For the last week, the stock has had daily average volatility of 3.00%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AUPH) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect Aurinia Pharmaceuticals Inc to open at $4.95, and during the day (based on 14 day Average True Range), to move between $4.76 and $5.24, which gives a possible trading interval of +/-$0.237 (+/-4.74%) up or down from last closing price. If Aurinia Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 9.47% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $4.99 (0.20%) than the resistance at $5.85 (17.00%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Aurinia Pharmaceuticals Inc stock A Buy?

Aurinia Pharmaceuticals Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.542 Sell Candidate Unchanged

Predicted Opening Price for Aurinia Pharmaceuticals Inc of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$4.95 ( 0.93%) $5.00

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AUPH

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.11 2.27 %
R2 5.05 1.04 %
R1 5.01 0.289 %
Current price: 5.00
Support S1 4.89 -2.16 %
S2 4.85 -2.91 %
S3 4.79 -4.13 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 6.02 20.40 %
R2 6.00 20.00 %
R1 5.85 17.00 %
Current price 5.00
Support S1 4.99 -0.200%
S2 4.97 -0.600%
S3 4.93 -1.40%

FAQ

What is the symbol for Aurinia Pharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for Aurinia Pharmaceuticals Inc is AUPH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aurinia Pharmaceuticals Inc Stock?
Aurinia Pharmaceuticals Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Aurinia Pharmaceuticals Inc Stock?
Aurinia Pharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aurinia Pharmaceuticals Inc Stock.

What's the current price of Aurinia Pharmaceuticals Inc Stock?
As of the end of day on the 2024-03-27, the price of an Aurinia Pharmaceuticals Inc (AUPH) share was $5.00.

What is the 52-week high and low for Aurinia Pharmaceuticals Inc Stock?
The 52-week high for Aurinia Pharmaceuticals Inc Stock is $12.42 and the 52-week low is $4.85.

What is the market capitalization of Aurinia Pharmaceuticals Inc Stock?
As of the 2024-03-27, the market capitalization of Aurinia Pharmaceuticals Inc is 723.09M.

When is the next earnings date for Aurinia Pharmaceuticals Inc?
The upcoming earnings date for Aurinia Pharmaceuticals Inc is May 02, 2024.
Click to get the best stock tips daily for free!

About Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.... AUPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT